TW
GILD icon

TrinityPoint Wealth’s Gilead Sciences GILD Stock Holding History

TrinityPoint Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$3.76M Sell
40,719
-2,887
-7% -$260K 0.53% 48
2024
Q3 		$3.66M Buy
43,606
+37,857
+658% +$2.89M 0.53% 45
2024
Q2 		$394K Sell
5,749
-137
-2% -$9.14K 0.06% 228
2024
Q1 		$431K Buy
5,886
+178
+3% +$13.7K 0.07% 212
2023
Q4 		$462K Buy
5,708
+159
+3% +$12.4K 0.08% 197
2023
Q3 		$416K Buy
5,549
+15
+0.3% +$1.15K 0.08% 196
2023
Q2 		$427K Sell
5,534
-322
-5% -$25.7K 0.08% 192
2023
Q1 		$486K Buy
5,856
+66
+1% +$5.47K 0.1% 175
2022
Q4 		$497K Buy
5,790
+637
+12% +$50.4K 0.11% 172
2022
Q3 		$318K Buy
5,153
+302
+6% +$19K 0.07% 196
2022
Q2 		$300K Buy
4,851
+33
+0.7% +$2.04K 0.07% 213
2022
Q1 		$286K Buy
4,818
+9
+0.2% +$575 0.05% 252
2021
Q4 		$349K Buy
4,809
+116
+2% +$7.99K 0.06% 230
2021
Q3 		$328K Buy
4,693
+217
+5% +$15.2K 0.06% 227
2021
Q2 		$308K Buy
4,476
+130
+3% +$8.68K 0.06% 212
2021
Q1 		$281K Sell
4,346
-54
-1% -$3.48K 0.07% 205
2020
Q4 		$293K Buy
4,400
+283
+7% +$17.1K 0.07% 194
2020
Q3 		$260K Buy
4,117
+63
+2% +$4.37K 0.07% 188
2020
Q2 		$312K Sell
4,054
-386
-9% -$29.6K 0.1% 162
2020
Q1 		$332K Sell
4,440
-17,026
-79% -$1.18M 0.13% 149
2019
Q4 		$1.4M Buy
21,466
+174
+0.8% +$11.3K 0.47% 56
2019
Q3 		$1.39M Buy
21,292
+145
+0.7% +$9.48K 0.48% 54
2019
Q2 		$1.41M Sell
21,147
-42
-0.2% -$2.76K 0.68% 39
2019
Q1 		$1.38M Buy
21,189
+8,434
+66% +$561K 0.68% 42
2018
Q4 		$798K Buy
+12,755
New +$892K 0.49% 62

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TrinityPoint Wealth's GILD Position: Q4 2024 in Review

TrinityPoint Wealth reduced its Gilead Sciences (GILD) stake by 6.6% in Q4 2024, selling an estimated $260K and leaving 40,719 shares worth $3.76M. The position accounts for 0.53% of the portfolio, ranked #48.

TrinityPoint Wealth first reported a position in GILD in Q4 2018 and has held it in 25 quarters since. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • TrinityPoint Wealth held 40,719 shares of Gilead Sciences worth $3.76M as of Q4 2024.
  • TrinityPoint Wealth sold 2,887 Gilead Sciences shares in Q4 2024, an estimated $260K.
  • Gilead Sciences made up 0.53% of TrinityPoint Wealth's portfolio in Q4 2024, its #48 holding.
  • TrinityPoint Wealth first reported a position in Gilead Sciences in Q4 2018 and has held it in 25 quarters since.
  • 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on TrinityPoint Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.